A BUDGET IMPACT ANALYSIS OF FIDAXOMICIN VERSUS VANCOMYCIN AND METRONIDAZOLE FOR THE TREATMENT OF CLOSTRIDIUM DIFFICILE

被引：0
|
作者：
Leinwand, B. [1 ]
机构：
[1] Avalere Hlth LLC, Washington, DC USA
来源：
VALUE IN HEALTH | 2017年 / 20卷 / 09期
关键词：
D O I：
10.1016/j.jval.2017.08.1426
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PGI7
引用
收藏
页码：A632 / A633
页数：2
相关论文
共 50 条
  • [41] Predictors for Treatment Failure With Fidaxomicin (FDX) and Vancomycin (VAN) in Clostridium difficile Infection (CDI)
    Louie, Thomas J.
    Golan, Yoav
    Mullane, Kathleen M.
    Miller, Mark
    Crook, Derrick W.
    Lentnek, Arnold
    Kean, Yin
    Gorbach, Sherwood L.
    GASTROENTEROLOGY, 2012, 142 (05) : S739 - S739
  • [42] A retrospective budget impact analysis of fidaxomicin treatment for Clostridioides difficile infections (CDI) in Germany
    Siefen, Ann-Cathrine
    Kurte, Melina Sophie
    Bauer, Anna Marie
    Cornely, Oliver A.
    Wingen-Heimann, Sebastian
    Kron, Florian
    EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2024, 24 (08) : 933 - 942
  • [43] Efficacy of Fidaxomicin versus Oral Vancomycin for Clostridium Difficile Infection in Solid Organ Transplant Recipients
    Tabriz, M.
    Reticker, A.
    Pettit, N.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2023, 23 (06) : S949 - S949
  • [44] A meta-analysis of metronidazole and vancomycin for the treatment of Clostridium difficile infection, stratified by disease severity
    Di, Xiuzhen
    Bai, Nan
    Zhang, Xin
    Liu, Bin
    Ni, Wentao
    Wang, Jin
    Wang, Kai
    Liang, Beibei
    Liu, Youning
    Wang, Rui
    BRAZILIAN JOURNAL OF INFECTIOUS DISEASES, 2015, 19 (04): : 339 - 349
  • [45] Oral fidaxomicin versus vancomycin for Clostridioides difficile infection
    Long, Brit
    Gottlieb, Michael
    ACADEMIC EMERGENCY MEDICINE, 2022, 29 (12) : 1506 - 1507
  • [46] Fidaxomicin vs Vancomycin for the Treatment of a First Episode of Clostridium Difficile Infection: A Meta-analysis and Systematic Review
    Al Momani, Laith A.
    Abughanimeh, Omar
    Boonpheng, Boonphiphop
    Gabriel, Joseph Gabriel
    Young, Mark
    CUREUS, 2018, 10 (06):
  • [47] Fidaxomicin, a new treatment for Clostridium difficile infections
    Cattoir, V.
    Tattevin, P.
    JOURNAL DES ANTI-INFECTIEUX, 2012, 15 (01) : 32 - 38
  • [48] Outcomes of Fidaxomicin Treatment of Clostridium difficile Infection
    Spiceland, Clayton
    Khanna, Sahil
    Pardi, Darrell
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2014, 109 : S196 - S196
  • [49] In vitro effect of metronidazole and vancomycin in combination on Clostridium difficile
    Hames, A.
    Perry, J. D.
    Gould, F. K.
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2009, 63 (05) : 1076 - 1076
  • [50] Budget Impact Analysis of Fidaxomicin Versus Vancomycin for the Treatment of Clostridioides difficile Infection in the United States (Jul, 10.1007/s40121-021-00480-0, 2022)
    Jiang, Yiling
    Sarpong, Eric M.
    Sears, Pamela
    Obi, Engels N.
    INFECTIOUS DISEASES AND THERAPY, 2022, 11 (01) : 127 - 127
12345